Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF‑κB and AP‑1.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7941, doi. 10.3892/ol.2017.7224
- By:
- Publication type:
- Article
Works by Zhuchen Yan
Results: 5
1
2
Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10637-4
- By:
- Publication type:
- Article
3
Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 111, doi. 10.1016/j.clcc.2022.10.007
- By:
- Publication type:
- Article
4
Metabolic and Immunological Implications of MME<sup>+</sup>CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities.
- Published in:
- Biological Procedures Online, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s12575-024-00254-1
- By:
- Publication type:
- Article
5
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 5, p. 1046, doi. 10.1007/s10120-024-01516-3
- By:
- Publication type:
- Article